For: | Ding H, Liu XC, Mei Q, Xu JM, Hu XY, Hu J. Ulcerative colitis flair induced by mesalamine suppositories hypersensitivity. World J Gastroenterol 2014; 20(13): 3716-3718 [PMID: 24707159 DOI: 10.3748/wjg.v20.i13.3716] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i13/3716.htm |
Number | Citing Articles |
1 |
Yingjie Si, LanJun Shao, Shanqing Gao, Hongzhu Wen. Suppository treatment in ulcerative proctitis. European Journal of Inflammation 2021; 19 doi: 10.1177/20587392211015108
|
2 |
M. Calafat, N. Depreux, M. Mañosa, E. Cabré, L. Zacarías, E. Domènech. Falsa hipersensibilidad a mesalazina como causa de escalamiento terapéutico. Enfermedad Inflamatoria Intestinal al Día 2015; 14(2): 65 doi: 10.1016/j.eii.2015.06.004
|
3 |
O. A. Sablin, V. V. Chernousova, A. D. Komlev. Lung disease/pneumonitis in a patient with ulcerative colitis due to mesalazine. Terapevticheskii arkhiv 2021; 93(2): 199 doi: 10.26442/00403660.2021.02.200618
|
4 |
Gabriella Varga, Melinda Ugocsai, Petra Hartmann, Norbert Lajkó, Réka Molnár, Szilárd Szűcs, Dávid Kurszán Jász, Dániel Érces, Miklós Ghyczy, Gábor Tóth, Mihály Boros. Acetylsalicylic acid-tris-hydroxymethyl-aminomethane reduces colon mucosal damage without causing gastric side effects in a rat model of colitis. Inflammopharmacology 2018; 26(1): 261 doi: 10.1007/s10787-017-0354-z
|
5 |
Myoungrin Park, Junguee Lee, Sang-Bum Kang, Yeonhee Park. Recurrent Eosinophilic Pneumonia Associated with Mesalazine Suppository in a Patient with Ulcerative Colitis. The Korean Journal of Gastroenterology 2019; 73(4): 225 doi: 10.4166/kjg.2019.73.4.225
|
6 |
|
7 |
Reetesh K. Pai, Gregory Y. Lauwers, Rish K. Pai. Measuring Histologic Activity in Inflammatory Bowel Disease: Why and How. Advances in Anatomic Pathology 2022; 29(1): 37 doi: 10.1097/PAP.0000000000000326
|
8 |
Henusha D. Jhundoo, Tobias Siefen, Alfred Liang, Christoph Schmidt, John Lokhnauth, Arnaud Béduneau, Yann Pellequer, Crilles Casper Larsen, Alf Lamprecht. Anti-Inflammatory Activity of Chitosan and 5-Amino Salicylic Acid Combinations in Experimental Colitis. Pharmaceutics 2020; 12(11): 1038 doi: 10.3390/pharmaceutics12111038
|